These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 92518)

  • 1. Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation.
    Kubagawa H; Vogler LB; Capra JD; Conrad ME; Lawton AR; Cooper MD
    J Exp Med; 1979 Oct; 150(4):792-807. PubMed ID: 92518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific detection of myeloma plasma cells using anti-idiotypic single chain antibody fragments selected from a phage display library.
    Willems PM; Hoet RM; Huys EL; Raats JM; Mensink EJ; Raymakers RA
    Leukemia; 1998 Aug; 12(8):1295-302. PubMed ID: 9697887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal anti-Id antibodies react with varying proportions of human B lineage cells.
    Kiyotaki M; Cooper MD; Bertoli LF; Kearney JF; Kubagawa H
    J Immunol; 1987 Jun; 138(12):4150-8. PubMed ID: 3495581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiotype-anti-idiotype network. II. Activation of silent clones by treatment at birth with idiotypes is associated with the expansion of idiotype-specific helper T cells.
    Rubinstein LJ; Yeh M; Bona CA
    J Exp Med; 1982 Aug; 156(2):506-21. PubMed ID: 6178788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Private idiotypes located on light and heavy chains of human myeloma proteins characterized by monoclonal antibodies.
    Hajighasemi F; Gharagozlou S; Ghods R; Khoshnoodi J; Shokri F
    Hybridoma (Larchmt); 2006 Dec; 25(6):329-35. PubMed ID: 17203994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiotype immunity (natural and vaccine-induced) in early stage multiple myeloma.
    Osterborg A; Henriksson L; Mellstedt H
    Acta Oncol; 2000; 39(7):797-800. PubMed ID: 11145435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-idiotype monoclonal antibodies specific for the MOPC167 anti-phosphocholine transgene-encoded antibody.
    Sieckmann DG; Martin E; Guelde G; Longo DL; Kenny JJ
    Hybridoma; 1997 Dec; 16(6):503-11. PubMed ID: 9455702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of shared idiotypes by paraproteins from patients with multiple myeloma and monoclonal gammopathy of undetermined significance.
    Berenson JR; Lichtenstein A; Hart S; Palomares D; Miller RA
    Blood; 1990 Jun; 75(11):2107-11. PubMed ID: 1693294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of the BALB/c antiphosphorylcholine antibody response at the precursor cell level.
    Gearhart PJ; Sigal NH; Klinman NR
    J Exp Med; 1975 Jan; 141(1):56-71. PubMed ID: 46913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deposition of idiotype-anti-idiotype immune complexes in renal glomeruli after polyclonal B cell activation.
    Goldman M; Rose LM; Hochmann A; Lambert PH
    J Exp Med; 1982 May; 155(5):1385-99. PubMed ID: 7040591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibition of myeloma cells by anti-idiotype antibodies in the absence of membrane-bound immunoglobulin.
    Moshitzky S; Kukulansky T; Haimovich J; Hollander N
    Immunol Cell Biol; 2008; 86(3):261-7. PubMed ID: 18195726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiotype-specific T lymphocytes. I. Regulation of antibody production by idiotype-specific H-2-restricted T lymphocytes.
    Yamamoto H; Bitoh S; Torii M; Fujimoto S
    J Immunol; 1983 Mar; 130(3):1038-42. PubMed ID: 6185567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiotype-recognizing T helper cells that are not idiotype specific.
    McNamara M; Kohler H
    J Exp Med; 1983 Sep; 158(3):811-21. PubMed ID: 6193235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of anti-idiotypic immune response by immunization with the autologous M-component protein in multiple myeloma patients.
    Bergenbrant S; Yi Q; Osterborg A; Björkholm M; Osby E; Mellstedt H; Lefvert AK; Holm G
    Br J Haematol; 1996 Mar; 92(4):840-6. PubMed ID: 8616076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiotypical identity of IgG myeloma protein with monoclonal IgM, Bence Jones protein, and Fv derived from one patient.
    Miyagawa N; Morita K; Azuma T
    Microbiol Immunol; 1990; 34(9):787-94. PubMed ID: 1704478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiotype-reactive T-cell subsets and tumor load in monoclonal gammopathies.
    Yi Q; Osterborg A; Bergenbrant S; Mellstedt H; Holm G; Lefvert AK
    Blood; 1995 Oct; 86(8):3043-9. PubMed ID: 7579398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor cell heterogeneity in multiple myeloma: antigenic, morphologic, and functional studies of cells from blood and bone marrow.
    King MA; Nelson DS
    Blood; 1989 May; 73(7):1925-35. PubMed ID: 2785420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity.
    Ciavarra RP; Vitetta ES; Forman J
    J Immunol; 1986 Aug; 137(4):1371-5. PubMed ID: 2426362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypical and functional characterization of the idiotype-positive blood B cells in multiple myeloma.
    Bloem AC; Chand MA; van Camp B; Bast EJ; Ballieux RE
    Scand J Immunol; 1988 Dec; 28(6):791-9. PubMed ID: 2906758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune responses of BALB/c mice to the idiotype of T15 and of other myeloma proteins of BALB/c origin: implications for an immune network and antibody multispecificity.
    Sakato N; Janeway CA; Eisen HN
    Cold Spring Harb Symp Quant Biol; 1977; 41 Pt 2():719-24. PubMed ID: 70307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.